Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(38)
•••
Comment by Chevelle454son Feb 20, 2019 1:25pm
133 Views
Post# 29388969

RE:RE:RE:Canopy/Globe & Mail/Christina Pellegrini

RE:RE:RE:Canopy/Globe & Mail/Christina Pellegrini
Firecat wrote:
PosterVi wrote: Whats crazy about all this is that she now works at Canopy and while the OSC / SEC should be all over this as it reeks of a "pay for play" deal with her. It will sadly take something like a short report to really open the eyes of all institutional investors about how bad not only the optics but actualy hiring of someone like Christina Pellegrini actually is when you piece together the biased articles she worte before joining Canopy. 

If Christina Pellegrini had worked for the Washington Post instead of the Globe and Mail etc,and had done what she has done, the lawsuits against Canopy Growth would be Fast And Furious

Firecat > Well said, I could not agree more!

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities